RSRGVFF

RSRGVFF (FOXP3 inhibitor P60) is a mixed-type angiotensin-converting enzyme (ACE) inhibitor with blood-brain barrier permeability, boasting an IC50 value of 5.01 μM[1]. RSRGVFF is capable of binding to both active and non-active sites of ACE and its substrate HHL complex, thus reducing the catalytic activity of ACE. RSRGVFF can be further utilized for research on lowering hypertension[1].

12352209

Angiotensin-converting Enzyme (ACE)

Metabolic Enzyme/Protease

Cardiovascular Disease

O=C(N[C@@H](CO)C(N[C@@H](CCCNC(N)=N)C(NCC(N[C@@H](C(C)C)C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CC2=CC=CC=C2)C(O)=O)=O)=O)=O)=O)=O)[C@H](CCCNC(N)=N)N

C40H61N13O9

867.99

[1]Lin Z, et al. Screening, ACE-inhibitory mechanism and structure-activity relationship of a novel ACE-inhibitory peptide from Lepidium meyenii (Maca) protein hydrolysate[J]. Food Bioscience, 2023, 52: 102374.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-P10808/

Peptides

No Development Reported